3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Completed
6
Terminated
2
Recruiting
2
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Myeloid
2
Conditions
Polycythemia Vera
2
Leukemia, Myeloid, Acute
2
Treatment-Refractory Solid Tumors
1
Squamous Cell Carcinoma of Head and Neck
1
Myelodysplastic Syndromes
1
Meningioma
1
Leukemia, Myelomonocytic, Chronic
1
Head and Neck Neoplasms
1
HPV-Negative Squamous Cell Carcinoma
1
Interventions
ruxolitinib
4
Specimen Handling
3
Biopsy
3
Hydroxyurea
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
talazoparib
1
piperine
1
iadademstat
1
givinostat hydrochloride
1
givinostat
1
fludarabine phosphate
1
fludarabine
1
fedratinib
1
demethoxycurcumin
1
decitabine and cedazuridine drug combination
1
bomedemstat
1
X-Rays
1
Whole-Body Irradiation
1
Watchful Waiting
1
Tacrolimus
1
Stem Cell Transplantation
1
Positron-Emission Tomography
1
N(4)-oleylcytosine arabinoside
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Interferons
1
Interferon-alpha
1
Injections
1
Hematopoietic Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Polycythemia Vera
×
Hydroxyurea
×
Clear all
NCT04116502
2026-04-28
MITHRIDATE
University of Birmingham
Phase 3
Recruiting
586 enrolled
NCT06093672
2026-03-25
GIV-IN-PV
Italfarmaco
Phase 3
Recruiting
220 enrolled